Skip to content
10-Q

Quarterly Report

CHINA PHARMA HOLDINGS, INC. CPHI

0001213900-25-109203

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 5.02M sh
Capex Q3 2025 · Sep 30, 2025 $58.87K
Capex Q3 2025 · Sep 30, 2024 $18.87K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$3.73K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$704.84K
Short Term Debt Q3 2025 · Sep 30, 2025 $1.41M
Short Term Debt Q3 2025 · Dec 31, 2024 $1.14M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $267.63K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $626.88K
Stockholders Equity Q3 2025 · Sep 30, 2025 $8.31M
Stockholders Equity Q3 2025 · Jun 30, 2025 $6.46M
Stockholders Equity Q3 2025 · Mar 31, 2025 $6.97M
Stockholders Equity Q3 2025 · Dec 31, 2024 $7.75M
Stockholders Equity Q3 2025 · Sep 30, 2024 $6.53M
Stockholders Equity Q3 2025 · Jun 30, 2024 $7.41M
Stockholders Equity Q3 2025 · Mar 31, 2024 $8.29M
Stockholders Equity Q3 2025 · Dec 31, 2023 $7.45M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.62M
Current Liabilities Q3 2025 · Dec 31, 2024 $5.02M
Total Liabilities Q3 2025 · Sep 30, 2025 $7.49M
Total Liabilities Q3 2025 · Dec 31, 2024 $7.14M
Current Assets Q3 2025 · Sep 30, 2025 $2.33M
Current Assets Q3 2025 · Dec 31, 2024 $3.27M
Total Assets Q3 2025 · Sep 30, 2025 $15.8M
Total Assets Q3 2025 · Dec 31, 2024 $14.89M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.17
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.57
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$0.65
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$2.25
Eps Basic Q3 2025 · Sep 30, 2025 −$0.17
Eps Basic Q3 2025 · Sep 30, 2025 −$0.57
Eps Basic restated Q3 2025 · Sep 30, 2024 −$0.65
Eps Basic restated Q3 2025 · Sep 30, 2024 −$2.25
Sga Expense Q3 2025 · Sep 30, 2025 $424.83K
Sga Expense Q3 2025 · Sep 30, 2025 $1.37M
Sga Expense Q3 2025 · Sep 30, 2024 $345.05K
Sga Expense Q3 2025 · Sep 30, 2024 $925.38K
Rd Expense Q3 2025 · Sep 30, 2025 $40.32K
Rd Expense Q3 2025 · Sep 30, 2025 $90.86K
Rd Expense Q3 2025 · Sep 30, 2024 $87.61K
Rd Expense Q3 2025 · Sep 30, 2024 $283.4K
Net Income Q3 2025 · Sep 30, 2025 −$651.48K
Net Income Q3 2025 · Sep 30, 2025 −$1.97M
Net Income Q3 2025 · Jun 30, 2025 −$528.37K
Net Income Q3 2025 · Mar 31, 2025 −$785.57K
Net Income Q3 2025 · Sep 30, 2024 −$1.12M
Net Income Q3 2025 · Sep 30, 2024 −$3.51M
Net Income Q3 2025 · Jun 30, 2024 −$1.44M
Net Income Q3 2025 · Mar 31, 2024 −$955.89K
Operating Income Q3 2025 · Sep 30, 2025 −$628.15K
Operating Income Q3 2025 · Sep 30, 2025 −$2.04M
Operating Income Q3 2025 · Sep 30, 2024 −$1.09M
Operating Income Q3 2025 · Sep 30, 2024 −$3.39M
Gross Profit Q3 2025 · Sep 30, 2025 −$59.65K
Gross Profit Q3 2025 · Sep 30, 2025 −$282.73K
Gross Profit Q3 2025 · Sep 30, 2024 −$519.65K
Gross Profit Q3 2025 · Sep 30, 2024 −$1.83M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $815.87K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $3.2M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $1.62M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $5.22M
Revenue Q3 2025 · Sep 30, 2025 $756.22K
Revenue Q3 2025 · Sep 30, 2025 $2.92M
Revenue Q3 2025 · Sep 30, 2024 $1.1M
Revenue Q3 2025 · Sep 30, 2024 $3.39M